🔗 Permalink

Inventor profile of:

David Kiewlich

City:

Alameda, California

Country:

United States

Published Applications:

Last publication date:

2024-05-09

Top Assignees for applications by David Kiewlich

The entities that hold a legal rights for patent applications filed by inventor Kiewlich David:

Wallkill BioPharma, Inc. 4 Rancho Santa Fe, CA United States
SDF BioPharma Inc. 3 Rancho Santa Fe, CA United States
SDF BIOPHARMA INC. 1 Mill Valley, CA United States
SDF BioPharma 1 San Diego, CA United States
BAYER HEALTHCARE LLC 1 Tarrytown, NY United States
Infinite Cells, LLC 1 Alameda, CA United States

Recent patent applications by Kiewlich David

David Kiewlich from Alameda, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-05-09

US20240150722A1

Chemistry; metallurgy

GENETICALLY MODIFIED STEM CELLS

#2 | 2022-05-12

US20220145262A1

Chemistry; metallurgy

Genetically modified stem cells

#3 | 2021-11-18

US20210355449A1

Chemistry; metallurgy

Genetically modified stem cells

#4 | 2020-12-31

US20200405772A1

Human necessities

Methods for reducing elevated glucose levels

#5 | 2020-09-10

US20200283731A1

Chemistry; metallurgy

Genetically modified stem cells

#6 | 2019-12-26

US20190390221A1

Chemistry; metallurgy

PLASMID VECTORS FOR EXPRESSION OF LARGE NUCLEIC ACID TRANSGENES

#7 | 2019-07-18

US20190218518A1

Chemistry; metallurgy

Treating diabetes with genetically modified beta cells

#8 | 2019-04-04

US20190100730A1

Chemistry; metallurgy

TREATING DIABETES WITH GENETICALLY MODIFIED BETA CELLS

#9 | 2019-04-04

US20190100729A1

Chemistry; metallurgy

TREATING DIABETES WITH GENETICALLY MODIFIED BETA CELLS

#10 | 2016-03-17

US20160074483A1

Human necessities

THERAPEUTIC PEPTIDE-EXPRESSING CELLS

#11 | 2012-07-12

US20120178693A1

Chemistry; metallurgy

Cofactors for Thrombin Activation of Factor VII and Uses Thereof

InventorID:

1472603 ⎘